online ISSN 2415-3176
print ISSN 1609-6371
logoExperimental and Clinical Physiology and Biochemistry
  • 9 of 11
Up
ECPB 2018, 84(4): 54–61
https://doi.org/10.25040/ecpb2018.04.054
Research articles

The Comparative Studies of the Immune Response to Biofilm and Planktonic Forms of Staphylococci

H. LAVRYK 1, O. KORNIYCHUK 1, J. FEDECHKO 2
Abstract

The insufficient efficiency of the specific treatment of purulent-inflammatory diseases with staphylococcal etiology depends on the ability of staphylococci to form biofilms. However, Staphylococcus aureus tries actively to modify the innate host response in vivo by reducing the production of proinflammatory cytokines and bypassing the traditional pathways of bacterial recognition. The purpose of the research is to compare the effect of the serums that are obtained from the immunization of rabbits with biofilm and the planktonic form of staphylococci on staphylococcal formation of films and phagocytosis of biofilm strains of S. aureus and also to determine the effect of biofilm and planktonic strains of staphylococci obtained from acne on induction of interleukin-1 by the lipopolylsaccharide of Escherichia coli. For the production of anti-biofilm form and anti-planktonic form of staphylococci serum, the rabbits of the chinchilla breed were immunized with the inactivated medications made of biofilm and planktonic strains of staphylococci. The research of the serum effects on the biofilm formation was performed by putting the serum antibodies to biofilm and planktonic form of staphylococci into the medium with serum dilutions from 1:10 to 1:40 with the addition of culture of biofilm and planktonic staphylococci forms. 0.2 ml of anti-biofilm serum was added to the test tube with staphylococci suspension to study the opsonization activity of serums and anti-planktonic serum was added in the same amount to the control tube. Then mixtures were incubated and separately added to the tubes with leukocytes. After that the phagocytic number and opsonic index were determined. The level of induction of IL-1 by the biofilm and plankton form of staphylococci was determined in a supernatant using a test system DRG (Germany) for ELISA. The results of research have demonstrated a delay in the formation of biofilms by the anti- biofilm form serum with dilutions 1:10 and 1:20. The specific serum for planktonic strain has demonstrated the effect of opsonization on their phagocytosis–the phagocytic number was 20.0 ± 0.87 cells/phagocyte (р < 0.001) and the opsonic index was 3.26. The anti-biofilm serum has stimulated the phagocytosis of biofilm forms of bacteria - the phagocytic number was 8.29 ± 0.71 cells/phagocyte and the opsonic index was 3.06. The induction of the level of IL-1 under the influence of culture fluid from biofilm forms of staphylococci has been two times higher than IL-1 induction with the action of the culture fluid from planktonic forms – 20.0 ± 1.23 pg/ml and 10.13 ± 0.69 pg/ml (Р < 0.05). The pre-incubation with the culture fluid from biofilm forms has decreased the induction of the synthesis of IL-1 by the lipopolysaccharides: the level of IL-1 in the control tube 2 (C2) 41.14 ± 1.04 pg/ml and the level of IL-1 with the culture fluid from planktonic forms – 25.25 ± 1.34 pg/ml. The serum antibodies to the biofilm form antigens of S.аureus obtained from the immunization of rabbits, inhibit the formation of the biofilm in vitro. Biofilm strains of S.aureus reduce the phagocytosis and the anti-biofilm serum partially causes the effect of opsonization. The reduction of synthesis of IL-1by the biofilm forms of staphylococcus promotes their avoidance of immune surveillance. This leads to the reduction of the maturation of immunocompetent cells in chronic and recurrent infections, including acne. Recieved: 12.11.2018

Keywords: biofilm, Staphylococcus aureus, serum, phagocytosis, interleukin-1

Full text: PDF (Ukr) 263K

References
  1. 1. Fätkenheuer G, Cornely O, Seifert H. Clinical management of catheter-related infections. Clinical Microbiology and Infection. 2002;8(9):545-50. doi.org/10.1046/j.1469-0691.2002.00427.x
  2. 2. Mann EE, Rice KC, Boles BR, Endres JL, Ranjit D, Chandramohan L et al. Modulation of eDNA release and degradation affects Staphylococcus aureus biofilm maturation. PloS one. 2009;4(6):e5822. doi.org/10.1371/journal.pone.0005822
  3. 3. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124(4):783-801. doi.org/10.1016/j.cell.2006.02.015
  4. 4. Lin YT, Verma A, P Hodgkinson C. Toll-like receptors and human disease: lessons from single nucleotide polymorphisms. Current Genomics. 2012;13(8):633-45. doi.org/10.2174/138920212803759712
  5. 5. Cerca N, Jefferson KK, Oliveira R, Pier GB, Azeredo J. Comparative antibody-mediated phagocytosis of Staphylococcus epidermidis cells grown in a biofilm or in the planktonic state. Infection and immunity. 2006;74(8):4849-55. doi.org/10.1128/IAI.00230-06
  6. 6. Zipfel C, Kunze G, Chinchilla D, Caniard AM, Jones JD, Boller T et al. Perception of the Bacterial PAMP EF-Tu by the Receptor EFR Restricts Agrobacterium-Mediated Transformation. Cell. 2006;125(4):749-60. doi.org/10.1016/j.cell.2006.03.037
  7. 7. Askarian F, Wagner T, Johannessen M, Nizet V. Staphylococcus aureus modulation of innate immune responses through Toll-like (TLRs),(NOD)-like (NLRs) and C-type lectin (CLRs) receptors. FEMS Microbiology Reviews. 2018;42(5):656-71. doi.org/10.1093/femsre/fuy025
  8. 8. Dziarski R. Recognition of bacterial peptidoglycan by the innate immune system. Cellular and Molecular Life Sciences CMLS. 2003;60(9):1793-804. doi.org/10.1007/s00018-003-3019-6
  9. 9. Morath S, Stadelmaier A, Geyer A, Schmidt R, Hartung T. Synthetic lipoteichoic acid from Staphylococcus aureus is a potent stimulus of cytokine release. Journal of Experimental Medicine. 2002;195(12):1635-40. doi.org/10.1084/jem.20020322
  10. 10. Ip WE, Sokolovska A, Charriere GM, Boyer L, Dejardin S, Cappillino MP et al. Phagocytosis and phagosome acidification are required for pathogen processing and MyD88- dependent responses to Staphylococcus aureus. The Journal of Immunology. 2010;184:7071-81. doi.org/10.4049/jimmunol.1000110
  11. 11. Shimada T, Park BG, Wolf AJ, Brikos C, Goodridge HS, Becker C A et al. Staphylococcus aureus evades lysozyme-based peptidoglycan digestion that links phagocytosis, inflammasome activation, and IL-1β secretion. Cell host & microbe. 2010;7(1):38-49. doi.org/10.1016/j.chom.2009.12.008
  12. 12. Vuong C, Voyich JM, Fischer ER, Braughton KR, Whitney AR, DeLeo FR et al. Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell Microbiol. 2004;6(3):269-75. doi.org/10.1046/j.1462-5822.2004.00367.x
  13. 13. Rigby KM, DeLeo FR. Neutrophils in innate host defense against Staphylococcus aureus infections. In Seminars in immunopathology. 2012;34(2):237-59. doi.org/10.1007/s00281-011-0295-3
  14. 14. Thurlow LR, Hanke ML, Fritz T, Angle A, Aldrich A, Williams SH et al. Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo. The Journal of Immunology. 2011;186(11):6585-96. doi.org/10.4049/jimmunol.1002794
  15. 15. Estellés A, Woischnig AK, Liu K, Stephenson R, Lomongsod E, Nguyen D et al. A High Affinity Native Human Antibody Disrupts Biofilm from Staphylococcus aureus Bacteria and Potentiates Antibiotic Efficacy in a Mouse Infectious Implant Model. Antimicrobial Agents and Chemotherapy. 2016;60(4):2292-301.doi.org/10.1128/AAC.02588-15
  16. 16. Xiong YQ, Estellés A, Li L, Abdelhady W, Gonzales R, Bayer AS et al. A human biofilm-disrupting monoclonal antibody potentiates antibiotic efficacy in rodent models of both Staphylococcus aureus and Acinetobacter baumannii infections. Antimicrobial Agents and Chemotherapy. 2017:61(10):e00904-17. doi.org/10.1128/AAC.00904-17
  17. 17. Vos P, Garrity G, Jones D, Krieg NR, Ludwig W, Rainey FA et al. Bergey's Manual of Systematic Bacteriology: Volume 3: The Firmicutes. Springer; 2009. 1450 р.
  18. 18. Prikaz MZ SSSR No 535 ot 22 aprelya 1985 g. ′′Ob unifikatsii mikrobiologicheskih (bakteriologicheskih) metodov issledovaniya, primenyaemyih v kliniko-diagnosticheskih laboratoriyah lechebno-profilakticheskih uchrezhdeniy′′. – M.; 1989. 126 s.
  19. 19. Tsyganenko AY, Lupai EV, Mishina MM, Gramatyuk SN. Study of antimicrobial action of Gatimak on plankton cells and biofilm of strains Staphylococcus aureus in vitro. Experimental and Clinical Medicine. 2012;1(54):11-3).
  20. 20. Law of Ukraine ′′On Protection of Animals From Cruel Treatment′′ of February 21, 2006, No. 3447-IV, with changes. The revision is valid from 04.08.2017.
  21. 21. Sidorchuk AS. Adenovirus Infection in Adults: Research of the Reactive Response of Polymorphonuclear Neutrophils. Actual Infectology. 2016;4(13):60-4).
  22. 22. Chepeleva MV, Chegurov OK, Kuznetsova EI, Shved NS. The indicators of immunity in patients with aseptic instability of knee joint. Klin Lab Diagn. 2014;59(8):18-21.
  23. 23. Shyrobokov VP. Medychna mikrobiolohiia, virusolohiia ta imunolohiia (pid red. akad. VP Shyrobokova). Vinnytsia: Nova knyha; 2011. 952 s.
  24. 24. Schommer NN, Christner M, Hentschke M, Ruckdeschel K, Aepfelbacher M, Rohde H. Staphylococcus epidermidis uses distinct mechanisms of biofilm formation to interfere with phagocytosis and activation of mouse macrophage-like cells 774A. 1. Infection and Immunity. 2011;79(6):2267-76. doi.org/10.1128/IAI.01142-10
  25. 25. Foster TJ. Immune evasion by staphylococci. Nat Rev Microbiol. 2005;3:948-58. doi.org/10.1038/nrmicro1289
  26. 26. O'neill LA. The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunological Review. 2008;226(1):10-8. doi.org/10.1111/j.1600-065X.2008.00701.x
  27. 27. Di Domenico EG, Cavallo I, Bordignon V, Prignano G, Sperduti I, Gurtner A et al. Inflammatory cytokines and biofilm production sustain Staphylococcus aureus outgrowth and persistence: a pivotal interplay in the pathogenesis of Atopic Dermatitis. Scientific Reports. 2018;8(1):9573. doi.org/10.1038/s41598-018-27421-1
  28. 28. Abramovits W, Bejarano JJR, Valdecantos WC. Role of interleukin 1 in atopic dermatitis. Dermatologic Clinics. 2013;31(3):437-44. doi.org/10.1016/j.det.2013.04.008
  29. 29. Krause K, Metz M, Makris M, Zuberbier T, Maurer M. The role of interleukin-1 in allergy-related disorders. Curr Opin Allergy Clin Immunol. 2012;12(5):477-84. doi.org/10.1097/ACI.0b013e3283574d0c
  30. 30. Hanke ML, Kielian T. Deciphering mechanisms of staphylococcal biofilm evasion of host immunity. Frontiers in Cellular and Infection Microbiology. 2012;2:62. doi.org/10.3389/fcimb.2012.00062


Програмування - Roman.im